UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | SEC 1473 (7-02) | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (Right to Buy) | Â (2) | 05/23/2026 | Common Stock | 33,333 | $ 2.18 (1) | D | Â |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
Marino Mark 3020 CALLAN ROAD SAN DIEGO, CA 92121 |
 |  |  Chief Medical Officer |  |
Jeremy Hayden, by Power of Attorney for Mark Marino | 08/22/2016 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | The reporting person received a non-qualified stock option granted under the Corporation's 2015 New Employee Incentive Plan. The exercise price per share to be paid by the reporting person at the time the option is exercised shall be the closing price of the Corporation's Common Stock on the NASDAQ Capital Market as of August 4, 2016, the date of the grant. The closing sale price on August 4, 2016 was $2.18. |
(2) | Twenty-five percent (25%) of the option shares shall vest on May 23, 2017 with the remaining option shares vesting in 36 equal monthly installments thereafter. |